Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Human Immunology
|
August 15, 2002
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients
HongXia Zheng, Steven Webber, Adriana Zeevi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 18, 2012
Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors
Kyle Jensen, L'Aurelle A Johnson, Pamala A Jacobson, et al.
Scientific Reports
|
July 2, 2025
Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation
Alexandra D Ladd, Isabella Angeli-Pahim, Duncan Lewis, et al.
Pharmacogenomics
|
December 1, 2015
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis
Yogita Ghodke-Puranik, Amrutesh S Puranik, Pooja Shintre, et al.
Journal of Clinical Pharmacology
|
March 22, 2005
Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypes
Hongxia Zheng, Erin Schuetz, Adriana Zeevi, et al.
Pediatric Blood & Cancer
|
April 13, 2023
Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders
Ally Fraser, Paul Castillo, Erika Cascio, et al.
Pharmacogenetics and Genomics
|
August 28, 2014
PharmGKB summary: gemcitabine pathway
Maria L Alvarellos, Jatinder Lamba, Katrin Sangkuhl, et al.
Bioinformatics (Oxford, England)
|
June 17, 2009
PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables
Stan Pounds, Cheng Cheng, Xueyuan Cao, et al.
Molecular Pharmacology
|
June 18, 2002
Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
Yvonne S Lin, Amy L S Dowling, Sean D Quigley, et al.
Clinical Pharmacology and Therapeutics
|
April 4, 2006
MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype
Jatinder Lamba, Stephen Strom, Raman Venkataramanan, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Human Immunology
|
August 15, 2002
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients
HongXia Zheng, Steven Webber, Adriana Zeevi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 18, 2012
Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors
Kyle Jensen, L'Aurelle A Johnson, Pamala A Jacobson, et al.
Scientific Reports
|
July 2, 2025
Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation
Alexandra D Ladd, Isabella Angeli-Pahim, Duncan Lewis, et al.
Pharmacogenomics
|
December 1, 2015
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis
Yogita Ghodke-Puranik, Amrutesh S Puranik, Pooja Shintre, et al.
Journal of Clinical Pharmacology
|
March 22, 2005
Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypes
Hongxia Zheng, Erin Schuetz, Adriana Zeevi, et al.
Pediatric Blood & Cancer
|
April 13, 2023
Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders
Ally Fraser, Paul Castillo, Erika Cascio, et al.
Pharmacogenetics and Genomics
|
August 28, 2014
PharmGKB summary: gemcitabine pathway
Maria L Alvarellos, Jatinder Lamba, Katrin Sangkuhl, et al.
Bioinformatics (Oxford, England)
|
June 17, 2009
PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables
Stan Pounds, Cheng Cheng, Xueyuan Cao, et al.
Molecular Pharmacology
|
June 18, 2002
Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
Yvonne S Lin, Amy L S Dowling, Sean D Quigley, et al.
Clinical Pharmacology and Therapeutics
|
April 4, 2006
MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype
Jatinder Lamba, Stephen Strom, Raman Venkataramanan, et al.
Page
of 4